Clinical Trial Update: A Study to Test How Well Different Doses of BI 3034701 Are Tolerated by Healthy Men and People With Overweight or Obesity [Phase 1]

View source ↗

Summary

Phase 1 study evaluating tolerability of differing doses of BI 3034701 in healthy men and individuals with overweight or obesity; the trial is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• BI 3034701

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Healthy | Phase 1 | Status: COMPLETED